Overall rank by patents
#32,048
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Inflectis ranks #32,048 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R32048 · Foreign Corporation #32,048 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Indian Space Research Organization (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Alkhorayef Petroleum · near
25 score
Clear LAM Packaging · near
25 score
Inflectis Bioscience · this assignee
25 score
Dupont Teijin… · near
25 score
Shenzhen Qianhai… · near
25 score
3D Lighting… · lowest
7 score
What this shows Inflectis's Innovation Score is 25.4/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Inflectis Bioscience is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2017. By volume, Inflectis sits between Indian Space Research Organization and Ingu Solutions Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Indian Space Research Organization
8 patents
Indian Statistical Institute
8 patents
Industrial Bank OF Korea
8 patents
Industro International Co., Ltd.
8 patents
Infopia Co., Ltd.
8 patents
Information System Engineering Inc.
8 patents
Ingine, Inc.
8 patents
Ingu Solutions Inc.
8 patents
Inflectis Bioscience
8 patents
What this shows Inflectis holds 8 patents at rank #32,009, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,009 in granted patent volume.
Other assignees with the most granted patents in Inflectis's primary technology class.
Two PlainPatent-derived peer sets for Inflectis, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (25 here).
Inflectis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 17th percentile higher than 17% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2020 | 4 | 50.0% |
| 2021 | 2 | 25.0% |
Top 5 of 5 technology areas
Overall rank by patents
#32,048
of 49,997 tracked assignees
25.4 out of 100
What to do with this data
Inflectis Bioscience's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.